Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
988.3 DKK | -8.81% | -9.69% | -25.69% |
03-27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
Official Publications
No official publication found
- Stock Market
- Equities
- ORPHA Stock
- News Orphazyme A/S
- Official Publications